Demand for GLP-1 Drugs Creates New Fraud Risks
/The explosive popularity of GLP-1 medications has created new challenges for insurers, health plans and fraud investigators, according to Stephanie Benson, CFE, senior manager in Evernorth Health Services’ Special Investigations Unit. During her virtual session at the 37th Annual ACFE Global Fraud Conference, she explored how social media-driven demand for weight loss drugs has contributed to emerging fraud schemes, misuse patterns and investigative concerns across the healthcare industry.
Read More


